IUG vs. EKF, CREO, NCYT, POLX, IHC, MHC, AVO, RUA, SUN, and BELL
Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), MyHealthChecked (MHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), and Belluscura (BELL). These companies are all part of the "medical devices" industry.
Intelligent Ultrasound Group vs.
EKF Diagnostics (LON:EKF) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.
EKF Diagnostics received 327 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.
EKF Diagnostics has a net margin of 9.37% compared to Intelligent Ultrasound Group's net margin of -34.56%. EKF Diagnostics' return on equity of 7.03% beat Intelligent Ultrasound Group's return on equity.
EKF Diagnostics has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.
In the previous week, EKF Diagnostics had 1 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 1 mentions for EKF Diagnostics and 0 mentions for Intelligent Ultrasound Group. Intelligent Ultrasound Group's average media sentiment score of 0.00 beat EKF Diagnostics' score of -1.10 indicating that Intelligent Ultrasound Group is being referred to more favorably in the news media.
70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.
Summary
EKF Diagnostics beats Intelligent Ultrasound Group on 10 of the 14 factors compared between the two stocks.
Get Intelligent Ultrasound Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for IUG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Ultrasound Group Competitors List
Related Companies and Tools
This page (LON:IUG) was last updated on 2/22/2025 by MarketBeat.com Staff
